Cinzia Campari

ORCID: 0000-0002-2535-568X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Global Cancer Incidence and Screening
  • Colorectal Cancer Screening and Detection
  • Cervical Cancer and HPV Research
  • Gastric Cancer Management and Outcomes
  • Digital Radiography and Breast Imaging
  • AI in cancer detection
  • Genetic factors in colorectal cancer
  • Endometrial and Cervical Cancer Treatments
  • Genital Health and Disease
  • Colorectal Cancer Treatments and Studies
  • Breast Cancer Treatment Studies
  • COVID-19 and healthcare impacts
  • Ethics in Clinical Research
  • Cancer Genomics and Diagnostics
  • Colorectal and Anal Carcinomas
  • Pancreatic and Hepatic Oncology Research
  • Cancer Risks and Factors
  • Ovarian cancer diagnosis and treatment
  • Diverticular Disease and Complications
  • Hepatitis B Virus Studies
  • Breast Lesions and Carcinomas
  • Radiomics and Machine Learning in Medical Imaging
  • Lung Cancer Treatments and Mutations
  • Gastrointestinal disorders and treatments
  • Congenital Heart Disease Studies

Istituti di Ricovero e Cura a Carattere Scientifico
2015-2024

Azienda Sanitaria Unità Locale di Reggio Emilia
2013-2024

Ospedale Santa Maria
2015-2018

Piedmont Reference Center for Epidemiology and Cancer Prevention
2016

Azienda Ospedaliera S.Maria
1999

Colorectal cancer (CRC) screening using the fecal occult blood test (FOBT) has been shown to be effective in reducing cause-specific mortality. However, although it detects pre-cancerous adenomas, is uncertain whether FOBT reduces incidence of invasive cancer. The objective evaluate impact with immunochemical (FIT) on CRC and mortality.An organized program was implemented 2005 province Reggio Emilia (Northern Italy). invites resident population aged 50-69 for FIT every 2 years. Subjects who...

10.1038/ajg.2015.240 article EN The American Journal of Gastroenterology 2015-08-25

Purpose To compare digital mammography (DM) plus breast tomosynthesis (DBT) versus DM alone for cancer screening in the Reggio Emilia Tomosynthesis trial, a two-arm test-and-treat randomized controlled trial. Materials and Methods For this eligible women (45–70 years old) who previously participated program were invited mammography. Consenting randomly assigned 1:1 to undergo DBT+DM or (both of which involved two projections double reading). Women treated according decision at DBT+DM....

10.1148/radiol.2018172119 article EN Radiology 2018-06-06

Background Adding digital breast tomosynthesis (DBT) to mammography (DM) improves cancer screening sensitivity, but how this impacts mortality and other end points is unknown. Purpose To compare interval overall incidence after with DBT plus DM versus alone. Materials Methods In prospective trial (RETomo), women attending were randomized one round of (experimental arm) or (control arm). All then rescreened 12 months (women aged 45–49 years) 24 (50–69 years). The primary outcome was...

10.1148/radiol.211132 article EN Radiology 2022-02-01
Paolo Giorgi Rossi Pamela Mancuso Pierpaolo Pattacini Cinzia Campari Andrea Nitrosi and 95 more Valentina Iotti Antonio Ponti Alfonso Frigerio Loredana Correale Emilia Riggi Livia Giordano Nereo Segnan Giovanni Di Leo Veronica Magni Francesco Sardanelli Francesca Fornasa Giovanna Romanucci Stefania Montemezzi Patrizia Falini Noemi Auzzi Marco Zappa Marta Ottone Paola Mantellini Stephen W. Duffy Paola Armaroli Chiara Coriani Manuela Pescarolo Gloria Stefanelli Giulio Tondelli Filippo Beretti Sabrina Caffarri Vanessa Marchesi Laura Canovi Marco Colli Mirco Boschini Marco Bertolini Moira Ragazzi Pierpaolo Pattacini Paolo Giorgi Rossi Valentina Iotti Vladimiro Ginocchi Sara Ravaioli Rita Vacondio Cinzia Campari Stefania Caroli Andrea Nitrosi Luca Braglia Silvio Cavuto Pamela Mancuso Olivera Djurić Francesco Venturelli Massimo Vicentini Maria Barbara Braghiroli Jasmine Lonetti Elena Davoli Efrem Bonelli Francesca Fornasa Stefania Montemezzi Giovanna Romanucci Ilaria Lucchi Gessica Martello Claudia Rossati Paola Mantellini Daniela Ambrogetti Anna Iossa Eva Carnesciali Vincenzo Mazzalupo Patrizia Falini Donella Puliti Marco Zappa Francesca Battisti Noemi Auzzi Simona Verdi Carolina Degl’Innocenti Daniela Tramalloni Elena Cavazza S. Busoni Elisa Betti Francesca Peruzzi Francesco Regini Francesco Sardanelli Giovanni Di Leo Luca Alessandro Carbonaro Veronica Magni Andrea Cozzi D. Spinelli Cristian Giuseppe Monaco Simone Schiaffino Adrienn Benedek Laura Menicagli Raffaella Ferraris Elisabetta Favettini Davide Dettori P. Di Falco Pietro Presti Nereo Segnan Antonio Ponti Alfonso Frigerio Paola Armaroli Loredana Correale

10.1016/j.ejca.2024.113553 article EN European Journal of Cancer 2024-01-21

To estimate the predictive role of faecal haemoglobin (f-Hb) concentration among subjects with immunochemical test (FIT) results below positivity cut-off for subsequent risk advanced neoplasia (AN: colorectal cancer-CRC-or adenoma).Prospective cohort aged 50-69 years, undergoing their first FIT between 1 January 2004 and 31 December 2010 in four population-based programmes Italy.All adopted same analytical procedure (OC Sensor, Eiken Japan), performed every 2 on a single sample, (20 µg Hb/g...

10.1136/gutjnl-2018-318198 article EN Gut 2019-08-27

Background & AimsThis cohort study compared colorectal cancer (CRC) incidence and mortality between people who participated in an Italian regional biennial fecal immunochemical test (FIT) screening program did not.MethodsThe started 2005. The target population included over 1,000,000 aged 50 to 69 years. FIT was a one-sample OC-Sensor (Eiken Chemical Co, Tokyo, Japan) (cutoff, ≥20 μg hemoglobin/g feces). average annual response rate invitation 51.4%. records of invited up June 2016 were...

10.1016/j.cgh.2022.01.053 article EN cc-by-nc-nd Clinical Gastroenterology and Hepatology 2022-02-07

This study aimed to evaluate the effectiveness of a biennial faecal immunochemical test (FIT) screening programme in reducing annual colorectal cancer (CRC) incidence its dynamic target population.The population included over 1,000,000 persons aged 50-69 living region northern Italy. The average response rate invitation was 51.4%. Each observed age-standardised (Europe) per 100,000 between 2005, year introduction programme, and 2016 compared with each expected as estimated age-period-cohort...

10.1038/s41416-022-01813-7 article EN cc-by British Journal of Cancer 2022-04-20

The aim of this study was to the emotional impact in-vitro fertilization (IVF) and any possible influence due type diagnosis, duration infertility, number cycles responses treatment. carried out on 200 patients admitted hospital for final stages IVF (oocyte retrieval embryo transfer). psychological measures taken into consideration were: state trait anxiety levels (Stait–Trait Anxiety), unconscious symptomatic anxiety, perception self others (EWI). Monitoring during hospitalization...

10.1093/humrep/14.12.3126 article EN Human Reproduction 1999-12-01

Abstract Background Improving the quality of information and communication is a priority in organised breast cancer screening an ethical duty. Programmes must offer each woman looking for, promoting informed decision-making. This study aimed to develop evaluate web-based dynamic decision aid (DA). Methods A pragmatic randomised trial carried out six regional programmes recruited women at first invitation receiving DA or standard brochure (SB). The primary outcome was choice measured on...

10.1038/s41416-020-0935-2 article EN cc-by British Journal of Cancer 2020-06-16

Abstract Short-term effects of air pollution on daily mortality and hospital admissions for respiratory causes are well documented. Few studies, however, explore the association between exposure to emergency room visits disorders, particularly in Italy among children as a susceptible population. A time-series analysis was conducted short-term pollutants (PM10, total suspended particulates [TSP], NO2, SO2, CO, O3) pediatric (ER) small city northern Italy, Reggio Emilia, during period...

10.1080/15287390600884784 article EN Journal of Toxicology and Environmental Health 2007-02-01

Cervical cancer screening programmes in Italy actively invite all 25-64-year-old resident women for the Pap test every 3 years irrespective of their citizenship. Immigrant come from countries where is absent or poorly implemented and prevalence human papillomavirus often high. These therefore have significant risk factors cervical cancer. The Italian Group Cancer Screening promoted a survey on participation positivity detection rates foreign 2009-2011. Aggregated data participation, cytology...

10.1097/cej.0000000000000173 article EN European Journal of Cancer Prevention 2015-07-24

The impact of the organised cervical cancer (CC) screening programmes implemented in Europe since 1990s has been insufficiently evaluated. We investigated changes CC incidence following introduction a programme Emilia-Romagna Region (northern Italy). study period was 1988-2013. programme, targeting women aged 25-64 years (1,219,000 2018), started 1998. annual rates that would be expected 1998-2013 absence were estimated, first, by analysing 1988-1997 with log-linear model and, second,...

10.1002/ijc.31806 article EN International Journal of Cancer 2018-08-18

The aim of this study is to evaluate the real impact COVID-19 during entire 2020 period, compared with 2019. data comes from a Cancer Registry in Northern Italy and we clinical treatment characteristics breast cancer by age, stage, treatment, status screening. In there was no decrease invasive tumours nor situ (513 vs. 493 76 73, respectively), while significant surgery increase neoadjuvant chemotherapy (p = 0.016). screening range (aged 45–74), change stage grading observed. four periods...

10.3390/cancers14123029 article EN Cancers 2022-06-20

This study compares the incidence and treatments of cervical neoplasia in foreigners from high migration countries Italians Reggio Emilia province (Northern Italy) 2002-2009. Standardized ratios (SIRs) 95% confidence intervals (95% CI) for intraepithelial grade 3 (CIN3) cancer were calculated versus Italian women; also classified according to prevalence human papillomavirus (HPV) their country origin. The proportion hysterectomies is presented as an indicator inappropriate surgery CIN3...

10.1097/cej.0000000000000137 article EN European Journal of Cancer Prevention 2015-02-25

In Emilia-Romagna, the Human Papillomavirus (HPV) vaccination campaign started in 2008 offering free vaccines for 1996 and 1997 cohorts. Systematic active invitation was implemented cohort. Our study aimed at measuring impact of on HPV vaccine coverage inequalities 11-year-old girls. Second, we evaluated effect participation cervical cancer screening by mothers target girls.We collected information status girls residing Reggio Emilia mothers' history, before after campaign. Log-binomial...

10.1136/bmjopen-2017-016189 article EN cc-by-nc BMJ Open 2017-09-01

Hereditary breast/ovarian cancer (HBOC) syndrome is caused by the inheritance of monoallelic germline BRCA1/2 gene mutations. If mutation carriers are identified before disease develops, effective actions against HBOC can be taken, including intensive screening, risk-reducing mastectomy and salpingo-oophorectomy, medications. The Italian National Prevention Plan mandates creation regional BRCA genetic testing programmes. So far, however, only informal data have been reported on their...

10.3390/mps7040063 article EN cc-by Methods and Protocols 2024-08-13
Coming Soon ...